Read the full stored bill text
SB1 INTRODUCED
Page 0
SB1
ARIXESQ-1
By Senator Weaver
RFD: Healthcare
First Read: 13-Jan-26
PFD: 15-May-25
1
2
3
4
5
6
ARIXESQ-1 05/14/2025 PMG (L)PMG 2025-1956
Page 1
PFD: 15-May-25
SYNOPSIS:
Existing law lists tetrahydrocannabinol (THC) as
a Schedule I controlled substance, but explicitly
exempts THC found in hemp.
Delta-8 THC, Delta-9 THC, and Delta-10 THC are
psychoactive cannabinoids that can be made from
hemp-derived cannabidiol (CBD).
This bill would provide that only
nonpsychoactive cannabinoids derived from or found in
hemp are exempt from the Schedule I controlled
substances list, thus classifying psychoactive
cannabinoids as controlled substances.
This bill would provide that products that are
ingested, whether orally or absorbed through the skin,
that contain cannabidiol (CBD) or other nonpsychoactive
cannibinoids found in or derived from hemp may only be
sold in licensed pharmacies that obtain certification
from the Alabama State Board of Pharmacy.
This bill would require the Alabama State Board
of Pharmacy to inspect pharmacies pursuant to this act.
This bill would require testing of consumable
hemp products prior to sale.
This bill would establish testing protocols for
testing of hemp and consumable hemp products.
This bill would provide that only consumable
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
SB1 INTRODUCED
Page 2
This bill would provide that only consumable
hemp products using hemp cultivated in this state may
be sold.
This bill would also require the Department of
Agriculture and Industries to establish a tracking
program of hemp and consumable hemp products as well as
the testing of these products.
A BILL
TO BE ENTITLED
AN ACT
Relating to hemp compounds; to require all ingestible
hemp products that contain nonpscyhoactive cannabinoids such
as cannabidiol (CBD) to be laboratory tested and only sold to
the public in licensed pharmacies that obtain a certification
from the Alabama State Board of Pharmacy; to establish testing
protocols and require safety testing of these products; to
limit the sale of consumable hemp products to products
containing hemp cultivated within the state; to require the
Department of Agriculture and Industries to establish a
seed-to-sale tracking system to track hemp cultivation through
the production and testing of consumable hemp products; to
amend Section 20-2-23, Code of Alabama 1975, to provide
further for tetrahydrocannabinol listed as a Schedule I
controlled substance; and to repeal Section 1 of Act 2025-385
of the 2025 Regular Session, which adds Chapter 12 to Title 28
of the Code of Alabama 1975, setting certain restrictions on
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
SB1 INTRODUCED
Page 3
of the Code of Alabama 1975, setting certain restrictions on
the distribution and sale of consumable hemp products and
requiring the Alabama Alcoholic Beverage Control Board to
license retailers of consumable hemp products.
BE IT ENACTED BY THE LEGISLATURE OF ALABAMA:
Section 1. As used in Sections 1 through 5, the
following terms have the following meanings:
(1) BOARD. The Alabama State Board of Pharmacy.
(2) CERTIFIED PHARMACY. A pharmacy that has obtained
certification from the board to sell consumable hemp products.
(3) CONSUMABLE HEMP PRODUCT. a. Any product intended to
be ingested or absorbed into the body which contains any
amount of a nonpsychoactive cannabinoid and includes the
following:
1. An oral tablet, capsule, or tincture.
2. A gummy.
3. A gel, oil, cream, or other topical preparation.
4. A suppository.
b. The term excludes:
1. Any product administered by smoking, combustion, or
vaping.
2. A beverage or food product, such as cookies or
candies.
3. Raw hemp plant material.
4. Any industrial hemp product regulated under Article
11 of Chapter 8 of Title 2, Code of Alabama 1975.
5. Any medical cannabis product regulated under Chapter
2A of Title 20, Code of Alabama 1975.
6. Any product approved by the United State Food and
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
SB1 INTRODUCED
Page 4
6. Any product approved by the United State Food and
Drug Administration.
(4) DEPARTMENT. The Department of Agriculture and
Industries.
(5) NONPSYCHOACTIVE CANNABINOID. A nonpsychoactive and
naturally occurring cannabinoid compound found in hemp, as
defined in Section 2-8-381, Code of Alabama 1975. The term
includes, but is not limited to, cannabidiol (CBD) and
cannabigerol (CBG). The term excludes any compound
synthetically produced from a cannibinoid.
(6) PROCESSOR. A person that produces consumable hemp
products.
Section 2. (a) On and after January 1, 2026, a
consumable hemp product may only be sold in the state by a
licensed pharmacy that meets the requirements of Sections 1
through 5 and only if the product has had a corresponding
certificate of analysis issued on its behalf by the
department.
(b) Any pharmacy that sells consumable hemp products on
and after January 1, 2026, must obtain certification on an
annual basis from the board, in a form prescribed by the
board, by rule. The board may charge a reasonable annual
filing fee, established by rule, to cover the costs of
administering this section.
(c) A certified pharmacy must maintain on its premises
the certificate of analysis issued by the department for each
consumable hemp product available for sale to the public.
(d) The board shall inspect all certified pharmacies no
less than annually to determine if the pharmacy meets the
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
SB1 INTRODUCED
Page 5
less than annually to determine if the pharmacy meets the
requirements of this section and rules of the board.
(e) The board shall revoke the certification of any
pharmacy that violates this section or a rule adopted pursuant
to subsection (f) and shall revoke the license of any pharmacy
that sells consumable hemp products on or after January 1,
2026, without obtaining a certification from the board.
(f) The board shall adopt rules as needed to implement
this section.
Section 3. (a) On and after January 1, 2026, consumable
hemp products may only contain nonpsychoactive cannabinoids
that are derived from hemp cultivated within the state.
(b) The department shall develop, or contract for the
development of, and maintain a seed-to-sale hemp tracking
system that tracks the cultivation of hemp plants; the
processing of nonpsychoactive cannabinboids into consumable
hemp products; and the testing of hemp plants and plant
material and consumable hemp products.
(c) Testing laboratories, hemp cultivators, processors,
the board, and the department shall all have the ability to
interface with the tracking system as needed, as determined by
the department.
Section 4. (a) The department, by rule, shall establish
protocols for random product testing, which may be conducted
during hemp cultivation, processing, and consumable hemp
product sales, to ensure consumable hemp products sold in this
state are consistently high grade, and maintain a consistency
with less than 0.5 percent variability among batches of the
same product. In addition, the protocols must provide for
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
SB1 INTRODUCED
Page 6
same product. In addition, the protocols must provide for
testing to allow the department to issue certificates of
analysis that correspond to consumable hemp products offered
for sale in this state, as further provided in subsection (f).
(b) The protocols for testing shall include the
following, as well as a determination of corresponding
tolerance limits:
(1) Cannabinoid content and potency, including, but not
limited to, all of the following:
a. Total THC (THC+THCA).
b. Total CBD (CBD+CBDA).
c. THC/CBD ratio, if applicable.
d. Percent of THC relative to original plant material
(w/w).
(2) Terpene profiles.
(3) Heavy metals.
(4) Chemical contamination, such as residual solvents
remaining after extraction and concentration.
(5) Microbials, including pathogenic microbials.
(6) Mycotoxins.
(7) Residual insecticides, fungicides, herbicides, and
growth regulators used during cultivation.
(c) The department shall collect a random sample of
hemp at the premises of a hemp cultivator, a processor, or
certified pharmacy for testing. In addition, processors shall
submit samples for testing to allow for the department to
issue a certificate of analysis prior to a consumable hemp
product being offered for sale to the public.
(d) The testing laboratory shall be accredited and
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
SB1 INTRODUCED
Page 7
(d) The testing laboratory shall be accredited and
shown to meet the requirements for a testing laboratory in
international standard ISO/IEC 17025, with the laboratory's
scope of accreditation demonstrating testing capabilities in
the categories of cannabinoids, pesticides, toxins, metals,
and microbiological bacteria.
(e) The testing laboratory shall implement procedures
and test methods directly linking the testing results to each
applicable source batch, product lot, and sample.
(f) The testing laboratory shall submit the test
results, through the seed-to-sale hemp tracking system, to be
reviewed by the department. The department shall verify
whether the test results indicate that the consumable hemp
product contains the specific nonpsychoactive cannabinoid
listed on a product's label and does not contain more than
trace amounts of a pscyhoactive cannabinoid, pesticide, toxin,
metal, or microbiological bacteria. If the department verifies
that the product meets these specific criteria, the department
shall issue a certificate of analysis corresponding to the
tested consumable hemp product.
(g) Costs associated with testing of hemp plants and
plant material shall be borne by the cultivator, and the costs
associated with testing of consumable hemp products shall be
borne by the processor.
Section 5. The department shall adopt rules to
implement and enforce Sections 1 through 5.
Section 6. Section 20-2-23, Code of Alabama 1975, is
amended to read as follows:
"§20-2-23
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
SB1 INTRODUCED
Page 8
"§20-2-23
(a) The Legislature finds the following:
(1) New synthetic substances are being created which
are not controlled under the provisions of existing state law
but which have a potential for abuse similar to or greater
than that for substances controlled under existing state law.
These new synthetic substances are called "synthetic
controlled substances or synthetic controlled substance
analogues" and can be designed to produce a desired
pharmacological effect and to evade the controlling statutory
provisions. Synthetic controlled substances or synthetic
controlled substance analogues are being manufactured,
distributed, possessed, and used as substitutes for controlled
substances.
(2) The hazards attributable to the traffic in and use
of a synthetic controlled substance or synthetic controlled
substance analogues are increased because their unregulated
manufacture produces variations in purity and concentration.
(3) Many new synthetic substances are untested, and it
cannot be immediately determined whether they have useful
medical or chemical purposes.
(4) The uncontrolled importation, manufacture,
distribution, possession, or use of controlled substance
analogues has a substantial and detrimental impact on the
health and safety of the people of this state.
(5) Synthetic controlled substances or synthetic
controlled substance analogues can be created more rapidly
than they can be identified and controlled by action of the
Legislature. There is a need for a speedy determination of
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
SB1 INTRODUCED
Page 9
Legislature. There is a need for a speedy determination of
their proper classification under existing law. It is
therefore necessary to identify and classify new substances
that have a potential for abuse, so that they can be
controlled in the same manner as other substances controlled
under existing state law.
(b) The controlled substances listed in this section
are included in Schedule I:
(1) Any of the following opiates, including their
isomers, esters, ethers, salts, and salts of isomers, esters ,
and ethers, unless specifically excepted, whenever the
existence of these isomers, esters, ethers , and salts is
possible within the specific chemical designation:
a. Acetylmethadol;
b. Allylprodine;
c. Alphacetylmethadol;
d. Alphameprodine;
e. Alphamethadol;
f. Benzethidine;
g. Betacetylmethadol;
h. Betameprodine;
i. Betamethadol;
j. Betaprodine;
k. Clonitazene;
l. Dextromoramide;
m. Dextrorphan;
n. Diampromide;
o. Diethylthiambutene;
p. Dimenoxadol;
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
SB1 INTRODUCED
Page 10
p. Dimenoxadol;
q. Dimepheptanol;
r. Dimethylthiambutene;
s. Dioxaphetyl butyrate;
t. Dipipanone;
u. Ethylmethylthiambutene;
v. Etonitazene;
w. Etoxeridine;
x. Furethidine;
y. Hydroxypethidine;
z. Ketobemidone;
aa. Levomoramide;
bb. Levophenacylmorphan;
cc. Morpheridine;
dd. Noracymethadol;
ee. Norlevorphanol;
ff. Normethadone;
gg. Norpipanone;
hh. Phenadoxone;
ii. Phenampromide;
jj. Phenomorphan;
kk. Phenoperidine;
ll. Piritramide;
mm. Proheptazine;
nn. Properidine;
oo. Racemoramide;
pp. Trimeperidine.
(2) Any of the following opium derivatives, their
salts, isomers , and salts of isomers, unless specifically
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
SB1 INTRODUCED
Page 11
salts, isomers , and salts of isomers, unless specifically
excepted, whenever the existence of these salts, isomers , and
salts of isomers is possible within the specific chemical
designation:
a. Acetorphine;
b. Acetyldihydrocodeine;
c. Benzylmorphine;
d. Codeine methylbromide;
e. Codeine-N-Oxide;
f. Cyprenorphine;
g. Desomorphine;
h. Dihydromorphine;
i. Etorphine;
j. Heroin;
k. Hydromorphinol;
l. Methyldesorphine;
m. Methyldihydromorphine;
n. Morphine methylbromide;
o. Morphine methylsulfonate;
p. Morphine-N-Oxide;
q. Myrophine;
r. Nicocodeine;
s. Nicomorphine;
t. Normorphine;
u. Pholcodine;
v. Thebacon.
(3) Any material, compound, mixture , or preparation
which contains any quantity of the following hallucinogenic
substances, their salts, isomers , and salts of isomers, unless
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
SB1 INTRODUCED
Page 12
substances, their salts, isomers , and salts of isomers, unless
specifically excepted, whenever the existence of these salts,
isomers , and salts of isomers is possible within the specific
chemical designation:
a. 3,4-methylenedioxy amphetamine;
b. 5-methoxy-3,4-methylenedioxy amphetamine;
c. 3,4,5-trimethoxy amphetamine;
d. Bufotenine;
e. Diethyltryptamine;
f. Dimethyltryptamine;
g. 4-methyl-2,5-dimethoxy amphetamine;
h. Ibogaine;
i. Lysergic acid diethylamide;
j. Marihuana Marijuana ;
k. Mescaline;
l. Peyote;
m. N-ethyl-3-piperidyl benzilate;
n. N-methyl-3-piperidyl benzilate;
o. Psilocybin;
p. Psilocyn;
q. Tetrahydrocannabinols, except for
tetrahydrocannabinols nonpsychoactive cannabinoids derived
from or found in hemp, as defined in Section 2-8-381.
(4)a. A synthetic controlled substance that is any
material, mixture, or preparation that contains any quantity
of the following chemical compounds, their salts, isomers , and
salts of isomers, unless specifically excepted, whenever the
existence of these salts, isomers , and salts of isomers is
possible within the specific chemical designation or compound:
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
SB1 INTRODUCED
Page 13
possible within the specific chemical designation or compound:
1. 3,4-Methylenedioxymethcathinone (Methylone), some
trade or other names: 3,4-methylenedioxy-N-methylcathinone.
2. 3,4-Methylenedioxypyrovalerone, some other trade
names: (MDPV).
3. 4-Methylmethcathinone (Mephedrone), some trade or
other names: 4-methylephedrone.
4. 4-Methoxymethcathinone (Methedrone), some trade or
other names: bk-PMMA.
5. 3-Fluoromethcathinone, some trade or other names:
3-FMC.
6. 4-Fluoromethcathinone (Flephedrone), some trade or
other names: 4-FMC.
7.
1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone,
some trade or other names: AM-694.
8.
1-[(5-fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone,
some trade or other names: AM-2201.
9. (6aR, 10aR)-9-(hydroxymethyl)-6,
6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[
c]chromen-1-ol, some trade or other names: HU-210.
10.
(6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-y
l)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol, some trade or
other names: HU-211, Dexanabinol.
11. 1-Pentyl-2-methyl-3-(1-naphthoyl)indole, some trade
or other names: JWH-007.
12.
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
SB1 INTRODUCED
Page 14
12.
(2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone,
some trade or other names: JWH-015.
13. Naphthalen-1-yl-(1-pentylindol-3-yl)methanone, some
trade or other names: JWH-018.
14. 1-Hexyl-3-(naphthalen-1-oyl)indole, some trade or
other names: JWH-019.
15. Naphthalen-1-yl-(butylindol-3-yl)methanone, some
trade or other names: JWH-073.
16.
4-Methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone, some
trade or other names: JWH-081.
17.
4-Methoxynaphthalen-1-yl-(1-pentyl-2-methylindol-3-yl)
methanone, some trade or other names: JWH-098.
18.
4-Methylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone, some
trade or other names: JWH-122.
19.
(1-(2-Morpholin-4-ylethyl)indol-3-yl)-naphthalen-1-ylmethanone
, some trade or other names: JWH-200.
20. 2-(2-Chlorophenyl)-1-(1-pentylindol-3-yl)ethanone,
some trade or other names: JWH-203.
21.
4-Ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone, some
trade or other names: JWH-210.
22. 2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone,
some trade or other names: JWH-250.
23.
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
SB1 INTRODUCED
Page 15
23.
5-(2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-1-ylmethano
ne, some trade or other names: JWH-307.
24. 1-Pentyl-3-(4-Chloro-1-naphthoyl)indole, some trade
or other names: JWH-398.
25.
2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol
(Cannabicyclohexanol), some trade or other names: CP 47, 497,
and homologues.
26.
2-(2-Methoxyphenyl)-1-[1-(2-cyclohexylethyl)indol-3-yl]ethanon
e, some trade or other names: RCS-8, SR-18.
27.
2-(4-Methoxyphenyl)-1-(1-pentyl-indol-3-yl)methanone, some
trade or other names: RCS-4.
28.
(R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1
,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone, some
trade or other names: WIN 55,212-2.
29.
(4-Methoxyphenyl)-[2-methyl-1-(2-morpholin-4-ylethyl)indol-3-y
l]methanone, some trade or other names: WIN 48,098,
Pravadoline.
b. In addition to any material, mixture, or preparation
that contains any quantity of the chemical compounds listed in
paragraph a., a synthetic controlled substance also includes
the following chemical compounds, their salts, isomers , and
salts of isomers, unless specifically excepted, whenever the
existence of these salts, isomers , and salts of isomers is
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
SB1 INTRODUCED
Page 16
existence of these salts, isomers , and salts of isomers is
possible within the specific chemical designation or compound:
1.
1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole,
some trade or other names: (AM-2233).
2. 1-Pentyl-3-(1-adamantoyl)indole, some trade or other
names: (AB001).
3.
[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-1-naphthale
nyl-methanone, some trade or other names: (AM1220).
4.
1-(5-Fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropyoyl)indole,
some trade or other names: (XLR11).
5. 1-Pentyl-3-(2,2,3,3-tetramethycyclopropoyl)indole,
some trade or other names: (UR-144).
6.
6-Methyl-2[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one,
some trade or other names: (URB 754).
7. [1,1'-biphenyl]-3-yl-carbamic acid, cyclohexyl
ester, some trade or other names: (URB 602).
8.
(3'-(Aminocarbonyl)[1,1'-biphenyl]-3-yl)-cyclohexylcarbamate,
some trade or other names: (URB597).
9. 1-(5-Fluoropentyl)-3-(4-methyl-1-naphthoyl)indole,
some trade or other names: (MAM2201).
10.
1-naphthalenyl[4-(pentyloxy)-naphthalenyl]methanone, some
trade or other names: (CB-13).
11.
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
SB1 INTRODUCED
Page 17
11.
1-(5-Chloropentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole,
some trade or other names: (5-Chloro-UR-144).
12.
1-(5-Fluoropentyl)-N-tricyclo[3,3,1,13,7]dec-1-yl-1H-indole-3-
carboxamide, some trade or other names: (STS-135).
13.
1[(N-Methylpiperidin-2-yl)methyl]-3-(adamant-1-oyl)indole,
some trade or other names: (AM1248).
14. N-Adamantyl-1-pentyl-1H-indole-3-carboxamide, some
trade or other names: (SDB-001, 2NE1).
15.
1-Pentyl-N-tricyclo[3,3,1,13,7]dec-1-yl-1H-indazole-3-carboxam
ide, some trade or other names: (AKB48, APINACA).
16. 3-Naphthoylindole.
17.
1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3-tetramethylcyclopropyl)i
ndole, some trade or other names: (A 796,260).
18.
1-[(tetrahydropyran-4-ylmethyl)-1H-indol-3-yl]-(2,2,3,3-tetram
ethylcyclopropyl)methanone, some trade or other names: (A
834,735).
19. 1-(Pent-4-en-1-yl)-3-(4-methyl-1-naphthoyl)indole,
some trade or other names: (JWH-122 4-pentenyl analog).
20.
N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)m
ethyl]-1H-indazole-3-carboxamide some trade or other names:
(AB-FUBINACA).
21.
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
SB1 INTRODUCED
Page 18
21.
[1-(5-bromopentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcycloprop
yl)methanone, some trade or other names: (5-Bromo-UR-144)
22.
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexylphenol,
some trade or other names: (CP-47,497 C8 homolog).
23.
1-(5-Fluoropentyl)-N-tricyclo[3,3,1,13,7]dec-1-yl-1H-indazole-
3-carboxamide, some trade or other names: (5F-AKB48,
5F-APINACA).
24. 1-(penta-4-ene)-3-(1-naphthoyl)indole, some trade
or other names: (JWH-022).
25. 1-(5-Chloropentyl)-3-(1-naphthoyl)indole, some
trade or other names: (Chloro-AM-2201, JWH-018
N-5-chloropentyl analog).
26. 1-(5-Hydroxypentyl)-3-(1-naphthoyl)indole, some
trade or other names: (Hydroxy-AM-2201).
27.
N-[(2E)-3-(2-Methoxyethyl)4,5-dimethyl-1,3-thiazole-2(3H)-ylid
ene]-2,2,3,3-tetramethylcyclopropane carboxamide, some trade
or other names: (A 836,339).
28. 1-Pentyl-3-(2-iodobenzoyl)indole, some trade or
other names: (AM 679).
29. 1-Pentyl-3-(2-methylphenacetyl)indole, some trade
or other names: (JWH-251).
30. 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl
ester, some trade or other names: (PB-22, QUPIC).
31. 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid
8-quinolinyl ester, some trade or other names: (5F-PB-22).
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
SB1 INTRODUCED
Page 19
8-quinolinyl ester, some trade or other names: (5F-PB-22).
32.
1-pentyl-N-(naphthalen-1-yl)-1H-indole-3-carboxamide, some
trade or other names: (MN-24, NNE1).
33. 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid
8-quinolinyl ester, some trade or other names: (BB-22,
QUCHIC).
34.
N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole -
-3-carboxamide, some trade or other names: (AB-PINACA).
35.
7-methoxy-1-(2-morpholinoethyl)-N-((1S,2S,4R)-1,3,3-trimethylb
icyclo[2.2.1]heptan-2-yl)-1H-indole-3-carboxamide, some trade
or other names: (MN-25).
36. ADB-PINACA.
37. FUB-AKB-48.
38. FUB-PB-22.
39. Heptyl-UR144.
40. THJ-018.
41. THJ-2201.
42. 1-heptyl-3-(1-napthoyl)indole), some trade or other
names: (JWH-20).
43. Napthalen-1-yl-(1-propyl-1H-indol-3-yl)methanone,
some trade or other names: (JWH-072).
44. (6aR,10aR)-3-(1, 1-Dimethylbutyl)-6a, 7, 10,
10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran, some
trade or other names: (JWH-133).
45. 3-(napthalen-1-ylmethyl)-1-pentyl-1H-indole, some
trade or other names: (JWH-175).
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
SB1 INTRODUCED
Page 20
trade or other names: (JWH-175).
46. 1-pentyl-3-(4-methoxyophenylacetyl)indole, some
trade or other names: (JWH-201).
47. 1-pentyl-3-(3-methoxyphenylacetyl)indole, some
trade or other names: (JWH 302).
48.
[(1R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7 -
-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]methanol, some trade or
other names: (HU-308).
49.
3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen -
-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione, some trade or
other names: (HU-331).
50.
N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecanamide,
some trade or other names: (CB-25).
51.
N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecanamide, some
trade or other names: (CB-52).
52.
2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-me
thyloctan-2-yl)phenol, some trade or other names:
(CB-55,940)(CB-55).
53. 4-Methylethylcathinone, some trade or other names:
(4-MEC, 4-Methylethcathinone).
54. 4'-Methyl-alpha-pyrrolidinopropiophenone, some
trade or other names: (MPPP, ZZ-1).
55.
(RS)-1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one, some
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
SB1 INTRODUCED
Page 21
(RS)-1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one, some
trade or other names: (Naphyrone).
56. alpha,alpha-Diphenyl-2-piperidinemethanol, some
trade or other names: (Pipradrol, Meratran).
57.
(RS)-1-(4-methylphenyl)-2-(1-pyrrolidinyl)pentan-1-one, some
trade or other names: (Pyrovalerone).
58. 3,4-Dimethylmethcathinone, some trade or other
names: (3,4-DMMC).
59. 4-Fluoroamphetamine, some trade or other names:
(4-FA).
60. 4-Fluoromethamphetamine, some trade or other names:
(4-FMA).
61. Butylone, some trade or other names: (bk-MBDB).
62. alpha-Pyrrolidinopentiophenone, some trade or other
names: (alpha-PVP).
63. beta-keto-Dimethylbenzodioxolylbutanamine, some
trade or other names: (bk-DMBDB).
64. 2-(methylamino)-1-phenylbutan-1-one, some trade or
other names: (Buphedrone).
65. (RS)-2-ethylamino-1-phenyl-propan-1-one, some trade
or other names: (N-Ethylcathinone).
66. 2-Fluoroamphetamine, some trade or other names:
(2-FA).
67. Methoxetamine, some trade or other names: (MXE).
68. 2-Methylamino-1-phenylpentan-1-one, some trade or
other names: (Pentedrone).
69. 3,4-Methylenedioxycathinone, some trade or other
names: (MDC).
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
SB1 INTRODUCED
Page 22
names: (MDC).
70. 2-Fluoromethamphetamine, some trade or other names:
(2-FMA).
71. 4-methylmethamphetamine, some trade or other names:
(4-MMA).
72. 4-Fluoroisocathinone, some trade or other names:
(4-FIC).
73. 3-Fluoromethamphetamine, some trade or other names:
(3-FMA).
74. Methiopropamine, some trade or other names: (MPA).
75. alpha-Pyrrolidinobutiophenone, some trade or other
names: (alpha-PBP).
76. 4-Methoxy-N-methylcathinone, some trade or other
names: (Methedrone, bk-PMMA).
77. alpha-Pyrrolidinopropiophenone, some trade or other
names: (alpha-PPP).
78. (RS)-2-benzhydrylpiperidine, some trade or other
names: (Desoxypipradrol).
79. 3,4-Methylenedioxyethylcathinone, some trade or
other names: (MDEC).
80. 3,4-Methylenedioxy-alpha-pyrrolidinobutiophenone,
some trade or other names: (MDPBP).
81.
1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one
(Pentylone, bk-MBDP).
82. 3-Fluoroamphetamine, some trade or other names:
(3-FA).
83. 3-Fluoromethcathinone, some trade or other names:
(3-FMC).
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
SB1 INTRODUCED
Page 23
(3-FMC).
84. 2-Fluoromethcathinone, some trade or other names:
(2-FMC).
85.
1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-one
(bk-MDDMA).
86. N,N-Diethylcathinone, some trade or other names:
(Amfepramone, DEC).
87. 1,3-Dimethylamylamine, some trade or other names:
(DMAA).
88. N, N-Dimethylcathinone, some trade or other names:
(DMC).
89. N-Ethyl-3,4-methylenedioxycathinone, some trade or
other names: (bk-MDEA).
90. N-Ethylamphetamine, some trade or other names:
(EMA).
91. N-Ethylcathinone, some trade or other names: (EC).
92. 2-Ethylethcathinone, some trade or other names:
(2-EEC).
93. 4-Ethyl-N-ethylcathinone, some trade or other
names: (4-EEC).
94.
2-(5-Methoxy-1-benzofuran-3-yl)-N,N-dimethylethanamine, some
trade or other names: (Dimembfe).
95. 2-(5-Methoxy-1-benzofuran-3-yl)N-ethylethamine.
96. 4-Methoxymethamphetamine, some trade or other
names: (PMMA).
97. 4-Methoxy-N-ethylamphetamine, some trade or other
names: (PMEA).
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
SB1 INTRODUCED
Page 24
names: (PMEA).
98. 4-Methoxy-N-ethylcathinone, some trade or other
names: (ETHEDRONE).
99. 3-Methylmethcathinone, some trade or other names:
(3-MMC).
100. 4-Methyl-alpha-pyrrolidinobutiophenone, some trade
or other names: (MPBP).
101. 2-Methylethcathinone, some trade or other names:
(2-MEC).
102. 3-Methylethcathinone, some trade or other names:
(3-MEC).
103. 2-Ethylethcathinone, some trade or other names:
(2-EEC).
104. 3-Ethylethcathinone, some trade or other names:
(3-EEC).
105. 3-Ethylmethcathinone, some trade or other names:
(3-EMC).
106.
3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone, some
trade or other names: (MDPPP).
107. alpha-Pyrrolidinopentiothiophenone, some trade or
other names: (alpha-PVT).
108. 3-Methoxymethcathinone, some trade or other names:
(3-MeOMC).
109. N-Methyl-1,3-benzodioxolylbutanamine, some trade
or other names: (MBDB).
110. Ethcathinone, some trade or other names:
(ETHYLPROPION, ETH-CAT).
111. Ethylone (3,4-methylenedioxy-N-ethylcathinone).
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
SB1 INTRODUCED
Page 25
111. Ethylone (3,4-methylenedioxy-N-ethylcathinone).
112. N-N-Diethyl-3,4-methylenedioxycathinone.
113. 3,4-methylenedioxy-propiophenone.
114. 2-Bromo-3,4-methylenedioxypropiophenone.
115. 3,4-methylenedioxy-propiophenone-2-oxime.
116. N-Acetyl-3,4-methylenedioxycathinone.
117. N-Acetyl-N-Methyl-3,4-methylenedioxycathinone.
118. N-Acetyl-N-Ethyl-3,4-methylenedioxycathinone.
119. 4-Bromomethcathinone.
120. 3-Bromomethcathinone.
121. Eutylone (beta-Keto-Ethylbenzodioxolylbutanamine).
122. 4'-Methoxy-alpha-pyrrolidinopropiophenone, some
trade or other names: (MOPPP).
123. 4'-Methyl-alpha-pyrrolidinohexiophenone, some
trade or other names: (MPHP).
124. Benocyclidine (BCP) or
Benzothiophenylcyclohexylpiperidine, some trade or other
names: (BTCP).
125. 4-Fluoro-(methylamino)butyrophenone, some trade or
other names: (F-MABP).
126. 3-Methyl-4-Methoxymethacathinone, some trade or
other names: (3-Me-4-MeO-MCAT).
127. 4-Methyl-(ethylamino)-butryophenone, some trade or
other names: (Me-EABP).
128. 4-Ethyl-methcathinone, some trade or other names:
(4-EMC).
129. 4-methoxy-N-ethylcathinone
(bk-PMC;p-methox-ethcathinone).
130. 4'-Methoxy-alpha-pyrroldino-propiophenone (MeOPPP;
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
SB1 INTRODUCED
Page 26
130. 4'-Methoxy-alpha-pyrroldino-propiophenone (MeOPPP;
4'-MeO-PPP).
131. 3-Fluorocathinone (3-FC).
132. 4-Fluorocathinone (4-FC).
133. 4-methyl-buphedrone (4-MeMABP; 4MeBP; BZ-6378).
134. 3,4-Methylenedioxy-N-benzylcathinone, some trade
or other names: (BMDP).
135. N-Benzyl-butylone, some trade or other names:
(BMDB).
136. N-Hydroxy-3,4-methlyenedioxymethcathinone.
137. N-ethylbuphedrone, some trade or other names:
(NEB).
138. 4-Fluorobuphedrone, some trade or other names:
(4-FBP).
139. 4-Methoxy-pyrrolidinbutrophenone (4-MeO-PBP).
140. 4-Ethyl-pyrrolidinobutrophenone, some trade or
other names: (4-Et-PBP).
141. 5-(2-aminopropyl)indole, some trade or other
names: (5-IT).
142. 1-phenyl-2-(piperidin-1-yl)butan-1-one.
143. 2,4,5-Trimethyl-methacathinone, some trade or
other names: (2,4,5-TMMC).
144. alpha-pyrrolidino-heptiophenone, some trade or
other names: (alpha-PHpP).
145. 4-Methylamphetamine (4-MA: pTAP; PAL-313; 4-MeA;
PmeA).
146. N-Ethyl-methamphetamine.
147. 4-(2-Aminopropyl)benzofuran, some trade or other
names: (4-APB).
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
SB1 INTRODUCED
Page 27
names: (4-APB).
148. 5-(2-Aminopropyl)-2,3-dihydro-1H-indene (5-APDI;
IAP; AIP; indanylaminoporpane).
149. 6,7-Methylenedioxy-2-aminotetralin, some trade or
other names: (MDAT).
150. 4-Methylthioamphetamine (4-MTA; P1882).
151. 4-Chloroamphetamine (p-chloro-amphetamine).
152. 2,4,6-Trimethoxyamphetamine, some trade or other
names: (TMA-6).
153. 2,4,5-Trimethoxyamphetamine, some trade or other
names: (TMA-2).
154. 2,5-Dimethylamphetamine, some trade or other
names: (2,5-DMA).
155. 3,4-Dimethylamphetamine, some trade or other
names: (3,4-DMA).
156. N-propylamphetamine.
157. 4-Hydroxyamphetamine.
158. 3-Hydroxyamphetamine.
159. Methylenedioxydimethylamphetamine, some trade or
other names: (MDDM).
160. 2-Aminoindane, some trade or other names: (2-AI).
161. 5,6-Methylenedioxy-N-methyl-aminoindane, some
trade or other names: (MDMAI).
162. 2C-T-21.
163. 2C-B-Fly.
164. 3,4-dimethyl-2,5-dimethoxyphenethylamine (2C-G).
165. 25D-NBOMe.
166. 25G-NBOMe.
167. 25N-NBOMe.
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
SB1 INTRODUCED
Page 28
167. 25N-NBOMe.
168. Bromo-benzyldifuranyl-isopropylamine, some trade
or other names: (Bromo Dragon Fly).
169. 3C-B fly.
170. 2,5-Dimethoxy-4-ethylthioamphetamine, some trade
or other names: (Aleph-2).
171. 1-[(4-ethoxy-2,5-dimethoxy)phenyl]propan-2-amine,
some trade or other names: (MEM).
172.
1-[2,5-dimethoxy-4-(propylthio)phenyl]propan-2-amine, some
trade or other names: (Aleph-7).
173. N-benzyl-2-phenylethylanamine.
174. N,N-dimethyl-2-phenylethanamine.
175. 6-chloro-2-aminotetralin, some trade or other
names: (6-CAT).
176. 2-phenylpropan-1-amine, some trade or other names:
(B-Me-PEA).
177. 2-Phenethylamine, some trade or other names:
(2-PEA).
178. 1-methylamino-1-(3,4-methylenedioxyphenyl)propane,
some trade or other names: (M-ALPHA).
179. Camfetamine.
180. Methoxyphenamine.
181. 4-methylaminorex, some trade or other names:
(4-MAR; 4-MAX; U4Euh; Euphoria; Ice).
182. (1-thiophen-2-yl)propan-2-amine
(Thienoamphetamine).
183. Dimethocaine.
184. 4-Fluoroephedrine.
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
SB1 INTRODUCED
Page 29
184. 4-Fluoroephedrine.
185. 4-methyaminorex (p-methyl derivative).
186.
1-[(N-methylpiperidin-2-yl)methyl]-2-methyl-3-(naphthalen-1-oy
l)-6-nitroindole (AM1221).
187. (1-butyl-1H-indol-3-yl)(4-methoxyphenyl)-methanone
(RCS-4 (C4) homolog).
188. 5-[3-(1-naphthoyl)-1H-indole-1-yl]pentanenitrile,
some trade or other names: (AM2232).
189. 1-(Pentyl)-3-(4-bromo-1-naphthoyl)-indole, some
trade or other names: (JWH-387).
190. 1-(Pentyl)-3-(4-fluoro-1-naphthoyl)-indole, some
trade or other names: (JWH-412).
191. 1-(5-chlorpentyl)-3-(2-iodobenzoyl)indole, some
trade or other names: (AM694 Derivative).
192.
(2-iodo-5-nitrophenyl)-[1-[(1-methylpiperidin-2-yl]methyl]1H-i
ndol-3-yl]-methanone, some trade or other names: (AM1241).
193. 1-Pentyl-3-[1-(4-propyl)naphthoyl]indole, some
trade or other names: (JWH-182).
194. JWH-081 2-methoxynaphthyl isomer, some trade or
other names: (JWH-267).
195.
(3-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone, some trade
or other names: (RCS-4 3-methoxy isomer).
196.
[1-(5-fluoropentyl)-1H-indol-3-yl](4-ethyl-1-naphthalenyl)-met
hanone (EAM-2201).
197. ADB-FUBINACA.
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
SB1 INTRODUCED
Page 30
197. ADB-FUBINACA.
198. ADBICA.
199. AM-279.
200. JWH-370.
201. NNE-1.
202. MAM-2201 chloropentyl derivative.
203. 1-(5-fluoropentyl)-3-(2-methyl-benzoyl)indole.
204. 1-(5-fluoropentyl)-3-(2-ethylbenzoyl)indole.
205. AB-005.
206. AB-005 Azepane isomer.
207.
4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-o
ne (4-HTMPIPO).
208. UR-12.
209. 5-Fluoro-ADBICA.
210. BAY-38-7271; KN 38-7271.
211. JTE-907.
212. Org 27569.
213. Org 27759.
214. Org 29647.
215. LY 2183240.
216. JTE 7-31.
217. URB 937.
218. 3-methoxy-eticyclidine, some trade or other names:
(3-MeO-PCE).
219. 1-Phenylcyclohexanamine, some trade or other
names: (PCA).
220. 4-Methyl-phencyclidine, some trade or other names:
(4-Me-PCP).
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
SB1 INTRODUCED
Page 31
(4-Me-PCP).
221. 4-Methoxy-eticyclidine, some trade or other names:
(4-MeO-PCE).
222. 4-Methoxyphencyclidine, some trade or other names:
(Methoxydine; 4MeO-PCP).
223. 3-Methoxyphencyclidine, some trade or other names:
(3-MeO-PCP).
224. 1-phenyl-N-propylcyclohexanamine, some trade or
other names: (PCPr).
225. N-(2-methoxyethyl)-1-phenylcyclohexanamine, some
trade or other names: (PCMEA).
226. N-(2-ethoxyethyl)-1-phenylcyclohexanamine, some
trade or other names: (PCEEA).
227. N-(3-methoxypropyl)-1-phenylcyclohexanamine, some
trade or other names: (PCMPA).
228. 3-Hydroxy-phencyclidine, some trade or other
names: (3-OH-PCP).
229. Methoxyketamine, some trade or other names:
(2-MeO-2-deschloro-ketamine).
230. Tiletamine, some trade or other names: (TCE).
231. N-ethylnorketamine.
232. N-Methyltryptamine, some trade or other names:
(NMT).
233. N-Methyl-N-isopropyltryptamine, some trade or
other names: (MiPT; MIPT).
234. 4-hydroxy-N,N-methylisopropyltryptamine, some
trade or other names: (4-OH-MiPT).
235. 4-Acetoxy-N,N-diisopropyl-tryptamine (4-AcO-DiPT:
4-AcO-DIPT; 4-Acetoxy-MiPT).
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
SB1 INTRODUCED
Page 32
4-AcO-DIPT; 4-Acetoxy-MiPT).
236. 4-Methoxy-N,N-dimethyltryptamine, some trade or
other names: (4-MeO-DMT).
237. 5-Hydroxytryptamine, some trade or other names:
(5-HT).
238. 5-acetoxy-N,N-dimethyltryptamine, some trade or
other names: (5-AcO-DMT).
239. 5-Methoxy-N,N-dipropyltryptamine, some trade or
other names: (5-MeO-DPT).
240. d-Lysergic acid amide, some trade or other names:
(LSA; ergine).
241. 2,5-dimethoxy-4-chloroamphetamine, some trade or
other names: (DOC).
242.
N-(2-Methoxybenzyl)-4-iodo-2,5-dimethoxyphenethylamine, some
trade or other names: (25I-NBOMe).
243. 4-Ethyl-2,5-dimethoxyphenethylamine, some trade or
other names: (2C-E).
244. 2,5-Dimethoxy-4-iodophenethylamine, some trade or
other names: (2C-I).
245. 6-(2-Aminopropyl)-2,3-dihydrobenzofuran, some
trade or other names: (6-APDB).
246. 6-(2-Aminopropyl)benzofuran, some trade or other
names: (6-APB).
247. 5-(2-Aminopropyl)-2,3-dihydrobenzofuran, some
trade or other names: (5-APDB).
248. 5-(2-Aminopropyl)benzofuran, some trade or other
names: (5-APB).
249. 2,5-Dimethoxy-4-(n)-propylthiophenethylamine, some
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
SB1 INTRODUCED
Page 33
249. 2,5-Dimethoxy-4-(n)-propylthiophenethylamine, some
trade or other names: (2C-T-7).
250. 2,5-Dimethoxy-4-(n)-propylphenethylamine, some
trade or other names: (2C-P).
251. 2,5-Dimethoxy-4-bromoamphetamine, some trade or
other names: (DOB).
252. 2,5-Dimethoxy-4-bromobenzylpiperazine, some trade
or other names: (2C-B-BZP).
253. 2,5-Dimethoxy-4-bromophenethylamine, some trade or
other names: (2C-B).
254. 2,5-Dimethoxy-4-chlorophenethylamine, some trade
or other names: (2C-C).
255. 2,5-Dimethoxy-(4-ethylthio)phenethylamine, some
trade or other names: (2C-T-2).
256. 2,5-Dimethoxy-4-iodoamphetamine, some trade or
other names: (DOI).
257. 2,5-Dimethoxy-4-methylamphetamine, some trade or
other names: (DOM).
258. 2,5-Dimethoxyphenethylamine, some trade or other
names: (2C-H).
259.
2-(2,5-Dimethoxyphenyl-4-bromo)-N-(2-methoxybenzyl)ethanamine,
some trade or other names: (25B-NBOMe).
260.
2-(2,5-Dimethoxyphenyl-4-chloro)-N-(2-methoxybenzyl)ethanamine
, some trade or other names: (25C-NBOMe).
261.
2-(2,5-Dimethoxyphenyl-4-ethyl)-N-(2-methoxybenzyl)ethanamine,
some trade or other names: (25E-NBOMe).
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
SB1 INTRODUCED
Page 34
some trade or other names: (25E-NBOMe).
262. 2-Ethylmethcathinone, some trade or other names:
(2-EMC).
263.
2-(2,5-Dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, some
trade or other names: (25H-NBOMe).
264. BZP (Benzylpiperazine).
265. para-Fluorophenylpiperazine.
266. 1-(4-Methylphenyl)piperazine.
267. meta-Cholorophenylpiperazine.
268. para-Methoxyphenylpiperazine.
269. DBZP (1,4-dibenzylpiperazine).
270. TFMPP (3-Trifluoromethylphenylpiperazine).
271. 2C-T-4
(2,5-Dimethoxy-4-isopropylthiophenethylamine.
272. 2C-T (2,5-Dimethoxy-4-methylthiophenethylamine).
273. 2C-D (2-(2,5-Dimethoxy-4-methylphenyl)ethanamine).
274. 2C-N 2,5-Dimethoxy-4-nitrophenethylamine.
275. 5-methoxy-N,N-diallyltryptamine, some trade or
other names: (5-MeO-DALT).
276. 5-Methoxy-N,N-Diisopropyltryptamine, some trade or
other names: (5-MeO-DIPT).
277. 5-Methoxy-alpha-methyltryptamine, some trade or
other names: (5-MeO-AMT).
278. 4-Acetoxy-N,N-dimethyltryptamine, some trade or
other names: (4-AcO-DMT).
279. 4-Hydroxy-N,N-diethyltryptamine, some trade or
other names: (4-HO-DET).
280. 4-Hydroxy-N,N-diisopropyltryptamine, some trade or
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
SB1 INTRODUCED
Page 35
280. 4-Hydroxy-N,N-diisopropyltryptamine, some trade or
other names: (4-HO-DIPT).
281. 4-Hydroxy-N-methyl-N-ethyltryptamine, some trade
or other names: (4-OH-MET).
282. 5-Methoxy-N,N-diethyltryptamine, some trade or
other names: (5-MeO-DET).
283. 5-Methoxy-N-methyl-N-isopropyltryptamine, some
trade or other names: (5-MeO-MIPT).
284. 4-Acetoxy-N,N-diethyltryptamine, some trade or
other names: (4-AcO-DET).
285. 4-Acetoxy-N-methyl-N-isopropyltryptamine, some
trade or other names: (4-AcO-MIPT).
286. N,N-Dipropyltryptamine, some trade or other names:
(DPT).
287. N,N-Diisopropyltryptamine, some trade or other
names: (DIPT).
288. 4-Methoxy-N-methyl-N-isopropyltryptamine, some
trade or other names: (4-MeO-MIPT).
289. Tyramine (4-Hydroxyphenethylamine).
290. 5-Hydroxy-alpha-methyltryptamine.
291. 5-Hydroxy-N-methyltryptamine.
292. 5-Methoxy-N,N-dimethyltryptamine.
293. 5-Methyl-N,N-dimethyltryptamine.
294. Diphenylprolinol, some trade or other names:
(D2PM; diphenyl-2-pyrrolidinemethanol).
295. 3,4 Dichloromethylphenidate, some trade or other
names: (3,4-CTMP).
296. 3-chloromethyl-phenidate, some trade or other
names: (3-CTMP).
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
SB1 INTRODUCED
Page 36
names: (3-CTMP).
297. 4-Methylmethylphenidate.
298. 4-Fluoromethyl-phenidate, some trade or other
names: (4-FTMP).
299. Ethylphenidate.
300. Etizolam (Etilaam, Etizola, Sedekopan, Pasaden,
Depas).
301. Phenazepam.
302. Pyrazolam.
303. CL-218,872.
304. Zopiclone.
305. Salvinorin A.
306. AH-7921.
307. O-Desmethyltramadol, some trade or other names:
(O-DT; ODT).
308. Desmorphine (Dihydrodesoxymorphine; permonid;
krokodil; crocodile).
309. Acetyl Fentanyl (desmethylfentanyl).
310. 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine
(MT-45).
311. 1-(2-methoxyphenyl)piperazine, some trade or other
names: (MOPIP).
312. 1-(4-Chlorophenyl)piperazine, some trade or other
names: (pCPP).
313. para-Methoxyphenyl-piperazine, some trade or other
names: (MBZP).
314. Methylmethaqualone.
315. Etaqualone.
316. 5-Iodo-2-aminoindane, some trade or other names:
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
1001
1002
1003
1004
1005
1006
1007
1008
SB1 INTRODUCED
Page 37
316. 5-Iodo-2-aminoindane, some trade or other names:
(5-IAI).
317. 5,6-(Methylenedioxy)-2-aminoindane, some trade or
other names: (5,6-MDAI).
318. 4,5-(Methylenedioxy)-2-aminoindane, some trade or
other names: (4,5-MDAI).
319. MMAI.
320. W-15.
321. W-18.
322. Mitragynine.
323. Hydroxymitragynine.
324. Butyrfentanyl
(N-phenyl-N-[1-(2-phenylethyl)-4-pyridinyl]butyramide).
325. Beta-Hydroxythiofentanyl
(N-phenyl-N-{1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperdinyl}-pr
opanamide).
326. 4-methylphenethyl acetyl fentanyl
(N-phenyl-N-{1-[2-(4-methylphenyl)ethyl]-4-piperdinyl}-acetami
de).
327. Acrylfentanyl
(N-phenyl-N-[1-(2-phenylethyl)-4-piperdinyl]-prop-2-enamide).
328. 3-Allylfentanyl
(N-phenyl-N-[1-(2-phenylethyl)-(3s,4R)-3-prop-2-enyl-4-piperid
inyl]-propanamide).
329. Benzodioxole fentanyl
(N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-benzo[d][1,3]dio
xole-5-carboxamide).
330. Benzyl carfentanil
(N-phenyl-N-(1-benzyl-4-methylcarboxylate-4-piperidinyl)-propa
1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
1021
1022
1023
1024
1025
1026
1027
1028
1029
1030
1031
1032
1033
1034
1035
1036
SB1 INTRODUCED
Page 38
(N-phenyl-N-(1-benzyl-4-methylcarboxylate-4-piperidinyl)-propa
namide).
331. Brifentanil
(N-(2-fluorophenyl)-N-{(3R,4S)-1-[2-(4-ethyl-5-oxotetrazol-1-y
l)ethyl]-3-methyl-4-piperdinyl}-2-methoxyacetamide).
332. Cyclopentylfentanyl
(N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl)-cyclopentanecarb
oxamide).
333. 2,5-Dimethylfentanyl
(N-phenyl-N-[1-(2-phenylethyl)-2,5-dimethyl-4-piperidinyl]-pro
pranamide).
334. 4-Fluoroisobutyryl fentanyl
(N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl)-isobut
yramide).
335. Furanyl fentanyl
(N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxami
de).
336. Furanylethyl fentanyl
(N-phenyl-N-[1-(2-furanylethyl)-4-piperidinyl]-propanamide).
337. Isobutyryl fentanyl
(N-phenyl-N-[1-(2-phenylethyl)-4-piperdinyl]-2-methylpropanami
de).
338. Lofentanil
(N-phenyl-N-[1-(2-phenylethyl)-(3R,4S)-3-methyl-4-methylcarbox
ylate-4-piperidinyl]-propanamide).
339. 4-Methoxybutyrfentanyl
(N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butyr
amide).
340. 4-Methoxymethylfentanyl
1037
1038
1039
1040
1041
1042
1043
1044
1045
1046
1047
1048
1049
1050
1051
1052
1053
1054
1055
1056
1057
1058
1059
1060
1061
1062
1063
1064
SB1 INTRODUCED
Page 39
340. 4-Methoxymethylfentanyl
(N-phenyl-N-[1-(2-phenylethyl)-4-methoxymethyl-4-piperidinyl]-
propanamide).
341. Meta-fluorobutyryl fentanyl
(N-(3-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidnyl)-butyram
ide).
342. Meta-fluorofentanyl
(N-(3-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidnyl)-propana
mide).
343. 3-Methylbutyrfentanyl
(N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butyramide).
344. N-Methylcarfentanyl
(N-phenyl-N-(1-methyl-4-methylcarboxylate-4-piperidinyl)-propa
namide).
345. Methoxyacetylfentanyl
(N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-2-methoxyacetami
de).
346. Mirfentanyl
(N-(2-pyrazinyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-2-furamid
e).
347. Ocfentanil
(N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperdinyl]-2-metho
xyacetamide).
348. Ohmefentanyl
(N-phenyl-N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidiny
l]-propanamide).
349. Ortho-fluorobutyryl fentanyl
(N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidnyl)-butyram
ide).
1065
1066
1067
1068
1069
1070
1071
1072
1073
1074
1075
1076
1077
1078
1079
1080
1081
1082
1083
1084
1085
1086
1087
1088
1089
1090
1091
1092
SB1 INTRODUCED
Page 40
ide).
350. Ortho-fluorofentanyl
(N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidnyl)-propana
mide).
351. Para-chlorofentanyl
(N-(4-chlorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propan
amide).
352. Para-chloroisobutyryl fentanyl
(N-(4-chlorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-isobut
yramide).
353. 4-Fluorobutyryl fentanyl
(N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butyra
mide).
354. Para-methoxyfentanyl
(N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propa
namide).
355. Para-methylfentanyl
(N-(4-methylphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propan
amide).
356. 4-Phenyl fentanyl
(N-phenyl-N-[4-phenyl-1-(2-phenylethyl)-4-piperidinyl]-propana
mide).
357. Trefentanyl
(N-(2-fluorophenyl)-N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetr
azol-1-yl)ethyl]-4-phenyl-4-piperdinyl}-propanamide).
358. Valeryl fentanyl
(N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-pentanamide).
359. Alpha-Methylacetylfentanyl
(N-phenyl-N-[1-phenylpropan-2-yl)-4-piperidinyl]-acetamide).
1093
1094
1095
1096
1097
1098
1099
1100
1101
1102
1103
1104
1105
1106
1107
1108
1109
1110
1111
1112
1113
1114
1115
1116
1117
1118
1119
1120
SB1 INTRODUCED
Page 41
(N-phenyl-N-[1-phenylpropan-2-yl)-4-piperidinyl]-acetamide).
360. Alpha-Methylbutyrfentanyl
(N-phenyl-N-[1-phenylpropan-2-yl)-4-piperidinyl]-butyramide).
361. Alpha-Methylthiofentanyl
(N-phenyl-N-[1-(1-thienyl-2-ylpropan-2-yl)-4-piperidinyl]-prop
anamide).
362. Beta-Hydroxy fentanyl
(N-phenyl-N-[1-(2-hydroxy-2-phenylethyl)-4-piperidinyl]-propan
amide).
363. Beta-Methyl fentanyl
(N-phenyl-N-[1-(2-phenylpropyl)-4-piperdinyl]-propanamide).
364. U-47700
(3,4-Dichloro-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]-N-methyl
benzamide).
365. W-19
((Z)-N-{1-[2-(4-aminophenyl)ethyl]piperidin-2-ylidene}-4-chlor
obenzenesulfonamide).
366. Flubromazolam
(8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a]
[1,4]benzodiazepine).
367. Tianeptine.
(5)a. A synthetic controlled substance analogue, being
a material, mixture, or preparation that contains any chemical
structure of which is chemically similar to the chemical
structure of any other controlled substance in Schedule I or
Schedule II or that satisfies any one of the following:
1. Has a stimulant, depressant, or hallucinogenic
effect on the central nervous system that mimics or is similar
to or greater than the stimulant, depressant, or
1121
1122
1123
1124
1125
1126
1127
1128
1129
1130
1131
1132
1133
1134
1135
1136
1137
1138
1139
1140
1141
1142
1143
1144
1145
1146
1147
1148
SB1 INTRODUCED
Page 42
to or greater than the stimulant, depressant, or
hallucinogenic effect on the central nervous system of a
controlled substance in Schedule I or Schedule II.
2. With respect to a particular person, if the person
represents or intends that the substance have a stimulant,
depressant, or hallucinogenic effect on the central nervous
system that is substantially similar to or greater than the
stimulant, depressant, or hallucinogenic effect on the central
nervous system of a controlled substance in Schedule I or
Schedule II and the substance is actually capable of producing
a stimulant, depressant, or hallucinogenic effect on the
central nervous system that mimics, is similar to, or is
greater than the stimulant, depressant, or hallucinogenic
effect on the central nervous system of a controlled substance
in Schedule I or Schedule II.
3. Has been demonstrated to have binding activity at
one or more cannabinoid receptors.
4. Is capable of exhibiting cannabinoid-like activity.
5. Any compound structurally analogous to, mimicking,
or derived from 3-(1-naphthoyl)indole or
1H-indol-3-yl-(1-naphthyl)methane by substitution at the
nitrogen atom of the indole ring by alkyl, alkyl halide, aryl
halide, alkyl aryl halide, alkenyl, aliphatic alcohol,
cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl whether or not further substituted
in the indole ring to any extent, whether or not substituted
in the naphthyl ring to any extent.
6. Any compound structurally analogous to, mimicking,
1149
1150
1151
1152
1153
1154
1155
1156
1157
1158
1159
1160
1161
1162
1163
1164
1165
1166
1167
1168
1169
1170
1171
1172
1173
1174
1175
1176
SB1 INTRODUCED
Page 43
6. Any compound structurally analogous to, mimicking,
or derived from 3-(1-naphthoyl)pyrrole by substitution at the
nitrogen atom of the pyrrole ring by alkyl, alkyl halide, aryl
halide, alkyl aryl halide, alkenyl, aliphatic alcohol,
cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl, whether or not further substituted
in the pyrrole ring to any extent, whether or not substituted
in the naphthyl ring to any extent.
7. Any compound structurally analogous to, mimicking,
or derived from 1-(1-naphthylmethyl)indene by substitution at
the 3-position of the indene ring by alkyl, alkyl halide, aryl
halide, alkyl aryl halide, alkenyl, aliphatic alcohol,
cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl whether or not further substituted
in the indene ring to any extent, whether or not substituted
in the naphthyl ring to any extent.
8. Any compound structurally analogous to, mimicking,
or derived from 3-phenylacetylindole by substitution at the
nitrogen atom of the indole ring with alkyl, alkyl halide,
aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol,
cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl, whether or not further substituted
in the indole ring to any extent, whether or not substituted
in the phenyl ring to any extent.
9. Any compound structurally analogous to, mimicking,
or derived from 2-(3-hydroxycyclohexyl)phenol by substitution
1177
1178
1179
1180
1181
1182
1183
1184
1185
1186
1187
1188
1189
1190
1191
1192
1193
1194
1195
1196
1197
1198
1199
1200
1201
1202
1203
1204
SB1 INTRODUCED
Page 44
or derived from 2-(3-hydroxycyclohexyl)phenol by substitution
at the 5-position of the phenolic ring by alkyl, alkyl halide,
aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol,
cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl, whether or not substituted in the
cyclohexyl ring to any extent.
10. Any compound structurally analogous to, mimicking,
or derived from 3-(2,2,3,3-tetramethylcyclopropoyl)indole or
1H-indol-3-yl-(2,2,3,3-tetramethylcyclopropoyl)methane by
substitution at the nitrogen atom of the indole ring by alkyl,
alkyl halide, aryl halide, alkyl aryl halide, alkenyl,
aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl whether or not further substituted
in the indole ring to any extent.
11. Any compound structurally analogous to, mimicking,
or derived from 3-(adamant-1-oyl)indole or
1H-indol-3-yl-(1-adamantyl)methane by substitution at the
nitrogen atom of the indole ring by alkyl, alkyl halide, aryl
halide, alkyl aryl halide, alkenyl, aliphatic alcohol,
cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl whether or not further substituted
in the indole ring to any extent.
12. Any compound structurally analogous to, mimicking,
or derived from N-(1-naphthalenyl)indole-3-carboxyamide or
1H-indol-(N-naphthyl)-3-carboxamide by substitution at the
nitrogen atom of the indole ring by alkyl, alkyl halide, aryl
1205
1206
1207
1208
1209
1210
1211
1212
1213
1214
1215
1216
1217
1218
1219
1220
1221
1222
1223
1224
1225
1226
1227
1228
1229
1230
1231
1232
SB1 INTRODUCED
Page 45
nitrogen atom of the indole ring by alkyl, alkyl halide, aryl
halide, alkyl aryl halide, alkenyl, aliphatic alcohol,
cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl whether or not further substituted
in the indole ring to any extent, whether or not substituted
in the naphthyl ring to any extent.
13. Any compound structurally analogous to, mimicking,
or derived from N-(adamantan-1yl)indole-3-carboxyamide or
1H-indol-3-carboxamide-(1-adamantyl) by substitution at the
nitrogen atom of the indole ring by alkyl, alkyl halide, aryl
halide, alkyl aryl halide, alkenyl, aliphatic alcohol,
cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl whether or not further substituted
in the indole ring to any extent.
14. Any compound structurally analogous to, mimicking,
or derived from N-(adamantan-1yl)indazole-3-carboxyamide or
1H-indazole-3-carboxamide-(1-adamantyl) by substitution at the
nitrogen atom of the indazole ring by alkyl, alkyl halide,
aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol,
cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl whether or not further substituted
in the indazole ring to any extent.
15. Any compound structurally analogous to, mimicking,
or derived from
N-[(1S)-1-(aminocarbonyl)-2-methylpropoyl]indazole-3-carboxyam
ide or
1233
1234
1235
1236
1237
1238
1239
1240
1241
1242
1243
1244
1245
1246
1247
1248
1249
1250
1251
1252
1253
1254
1255
1256
1257
1258
1259
1260
SB1 INTRODUCED
Page 46
ide or
1H-indazole-3-carboxamide-N-[(1S)-1-(aminocarbonyl)-2-methylpr
opoyl] by substitution at the nitrogen atom of the indazole
ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide,
alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl whether or not further substituted
in the indazole ring to any extent.
16. Any compound structurally analogous to, mimicking,
or derived from 3-(1-naphthoyl)indazole or
1H-indazole-3-yl-(1-naphthyl)methane by substitution at the
nitrogen atom of the indazole ring by alkyl, alkyl halide,
aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol,
cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl whether or not further substituted
in the indazole ring to any extent, whether or not substituted
in the naphthyl ring to any extent.
17. Any compound structurally analogous to, mimicking,
or derived from 3-(carboxylic acid 8-quinolinyl ester)indole
or 1H-indol-3-carboxylic acid-(8-quinolinyl)ester by
substitution at the nitrogen atom of the indole ring by alkyl,
alkyl halide, aryl halide, alkyl aryl halide, alkenyl,
aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl,
(N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,
or 2-(4-morpholinyl)ethyl whether or not further substituted
in the indole ring to any extent, whether or not substituted
in the quinoline ring to any extent.
18. Any compound structurally related to
1261
1262
1263
1264
1265
1266
1267
1268
1269
1270
1271
1272
1273
1274
1275
1276
1277
1278
1279
1280
1281
1282
1283
1284
1285
1286
1287
1288
SB1 INTRODUCED
Page 47
18. Any compound structurally related to
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine by substitution of
the iodo moiety (4 position) with other halides, alkyl, alkyl
halides, thioalkyl, cycloalkyl, cycloalkylhalides and/or
substitution at the nitrogen atom of the ethanamine with
alkyl, alkyl halide, alkenyl, cycloalkylmethyl,
cycloalkylethyl, phenyl, benzyl whether or not further
substituted in the (either) phenyl ring to any extent.
19. Any compound structurally related to
2,5-dimethoxy-4-chloroamphetamine by substitution of the
chloro moiety (4 position) with other halides, alkyl, alkyl
halides, thioalkyl, cycloalkyl, cycloalkylhalides and/or
substitution at the nitrogen atom with alkyl, alkyl halide,
alkenyl, cycloalkylmethyl, cycloalkylethyl, phenyl, benzyl
whether or not further substituted in the (either) phenyl ring
to any extent.
20. Any compound structurally related to
2-amino-1-phenyl-1-propanone (cathinone) by substitution of
the amine with alkyl, alkyl halide, alkenyl, cycloalkylmethyl,
cycloalkylethyl, phenyl, benzyl whether or not further
substituted in the (either) phenyl ring to any extent.
21. Any compound structurally related to
a-pyrrolidinopentiophenone (a-pvp) whether or not further
substituted in the phenyl ring to any extent, whether or not
further substituted in the pyrrolidine ring to any extent.
b. A synthetic controlled substance or analogue in
subdivision (4) or this subdivision does not include any of
the following:
1. Any substance for which there is an approved new
1289
1290
1291
1292
1293
1294
1295
1296
1297
1298
1299
1300
1301
1302
1303
1304
1305
1306
1307
1308
1309
1310
1311
1312
1313
1314
1315
1316
SB1 INTRODUCED
Page 48
1. Any substance for which there is an approved new
drug application under the Federal Food, Drug, and Cosmetic
Act.
2. With respect to a particular person, any substance,
if an exemption is in effect for investigational use, for that
person, as provided by 21 U.S.C. § 355, and the person is
registered as a controlled substance researcher as required
under section Section 152.12, subdivision Subdivision 3, to the
extent conduct with respect to the substance is pursuant to
the exemption and registration.
c. A controlled substance analogue is treated as a
controlled substance in Schedule I.
d. After the Alabama Department of Forensic Sciences
has determined a substance to be a synthetic controlled
substance analogue under this section, the department shall
notify the Alabama Department of Public Health with
information relevant to scheduling as provided by Section
20-2-20."
Section 7. Section 1 of Act 2025-385 of the 2025
Regular Session, which adds Chapter 12 to Title 28 of the Code
of Alabama 1975, establishes certain restrictions on the
distribution and sale of consumable hemp products, and
requires the Alabama Alcoholic Beverage Control Board to
license retailers of consumable hemp products, is repealed.
Section 8. This act shall become effective on July 1,
2026.
1317
1318
1319
1320
1321
1322
1323
1324
1325
1326
1327
1328
1329
1330
1331
1332
1333
1334
1335
1336
1337
1338
1339
1340
1341